Literature DB >> 16943339

Should desperate volunteers be included in randomised controlled trials?

P Allmark1, S Mason.   

Abstract

Randomised controlled trials (RCTs) sometimes recruit participants who are desperate to receive the experimental treatment. This paper defends the practice against three arguments that suggest it is unethical first, desperate volunteers are not in equipoise. Second clinicians, entering patients onto trials are disavowing their therapeutic obligation to deliver the best treatment; they are following trial protocols rather than delivering individualised care. Research is not treatment; its ethical justification is different. Consent is crucial. Third, desperate volunteers do not give proper consent: effectively, they are coerced. This paper responds by advocating a notion of equipoise based on expert knowledge and widely shared values. Where such collective, expert equipoise exists there is a prima facie case for an RCT. Next the paper argues that trial entry does not involve clinicians disavowing their therapeutic obligation; individualised care based on insufficient evidence is not in patients best interest. Finally, it argues that where equipoise exists it is acceptable to limit access to experimental agents; desperate volunteers are not coerced because their desperation does not translate into a right to receive what they desire.

Entities:  

Mesh:

Year:  2006        PMID: 16943339      PMCID: PMC2563406          DOI: 10.1136/jme.2005.014282

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  42 in total

1.  The therapeutic orientation to clinical trials.

Authors:  Franklin G Miller; Donald L Rosenstein
Journal:  N Engl J Med       Date:  2003-04-03       Impact factor: 91.245

2.  The ubiquity and utility of the therapeutic misconception.

Authors:  Rebecca Dresser
Journal:  Soc Philos Policy       Date:  2002

3.  Rehabilitating equipoise.

Authors:  Paul B Miller; Charles Weijer
Journal:  Kennedy Inst Ethics J       Date:  2003-06

4.  Clinical equipoise and the therapeutic misconception.

Authors:  Howard Mann; Benjamin Djulbegovic
Journal:  Hastings Cent Rep       Date:  2003 Sep-Oct       Impact factor: 2.683

Review 5.  Ethics of clinical trials from a bayesian and decision analytic perspective: whose equipoise is it anyway?

Authors:  Richard J Lilford
Journal:  BMJ       Date:  2003-05-03

6.  Update on unethical use of placebos in randomised trials.

Authors:  Karin B Michels; Kenneth J Rothman
Journal:  Bioethics       Date:  2003-04       Impact factor: 1.898

7.  A critique of clinical equipoise. Therapeutic misconception in the ethics of clinical trials.

Authors:  Franklin G Miller; Howard Brody
Journal:  Hastings Cent Rep       Date:  2003 May-Jun       Impact factor: 2.683

8.  Therapeutic obligation in clinical research.

Authors:  Charles Weijer; Paul B Miller
Journal:  Hastings Cent Rep       Date:  2003 May-Jun       Impact factor: 2.683

9.  Issues to debate on the Women's Health Initiative (WHI) study. Epidemiology or randomized clinical trials--time out for hormone replacement therapy studies?

Authors:  Anette Tønnes Pedersen; Bent Ottesen
Journal:  Hum Reprod       Date:  2003-11       Impact factor: 6.918

Review 10.  Ethical issues in human prion diseases.

Authors:  S J Tabrizi; C L Elliott; C Weissmann
Journal:  Br Med Bull       Date:  2003       Impact factor: 4.291

View more
  6 in total

1.  Ethical challenges in conducting clinical research in lung cancer.

Authors:  Peter Allmark; Angela M Tod
Journal:  Transl Lung Cancer Res       Date:  2016-06

2.  Evidence-based medicine in obstetrics: can levels B and C recommendations be elevated to level A recommendations?

Authors:  Suneet P Chauhan; Eugene Chang; Brian Brost; Barbara Assel; Jason Baxter; James A Smith; Robert Grobman; Vincenzo Berghella; James A Scardo; Everett F Magann; John C Morrison
Journal:  Obstet Med       Date:  2009-05-22

3.  How informed is consent in vulnerable populations? Experience using a continuous consent process during the MDP301 vaginal microbicide trial in Mwanza, Tanzania.

Authors:  Andrew Vallely; Shelley Lees; Charles Shagi; Stella Kasindi; Selephina Soteli; Natujwa Kavit; Lisa Vallely; Sheena McCormack; Robert Pool; Richard J Hayes
Journal:  BMC Med Ethics       Date:  2010-06-13       Impact factor: 2.652

4.  Ethical Issues in Deep Brain Stimulation Research for Treatment-Resistant Depression: Focus on Risk and Consent.

Authors:  Laura B Dunn; Paul E Holtzheimer; Jinger G Hoop; Helen S Mayberg; Paul S Appelbaum
Journal:  AJOB Neurosci       Date:  2011

5.  The TOTAL trial dilemma: A survey among professionals on equipoise regarding fetal therapy for severe congenital diaphragmatic hernia.

Authors:  Simen Vergote; Daniel Pizzolato; Francesca Russo; Kris Dierickx; Jan Deprest; Neeltje Crombag
Journal:  Prenat Diagn       Date:  2020-11-05       Impact factor: 3.242

Review 6.  The ethical issues regarding consent to clinical trials with pre-term or sick neonates: a systematic review (framework synthesis) of the analytical (theoretical/philosophical) research.

Authors:  Christopher Megone; Eleanor Wilman; Sandy Oliver; Lelia Duley; Gill Gyte; Judy Wright
Journal:  Trials       Date:  2016-09-09       Impact factor: 2.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.